The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And so I ended up in these consortiums pulling in the genome sequencing companies, developing the technology to work with us to improve it further and the computer science guys who then take that data and that technology, and try to make the complete genomes and make the algorithms better to produce what we now just did recently led by an effort by Adam Phillippy is the first human Telomere-to-Telomere Genome with no errors, all complete, no missing sequence.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.